ImmuCell Corporation — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f25ea1d5-69f9-4684-8f91-b720788eaca3/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.0M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-012259 |
| FY 2024 | $-2.2M | 2024-01-01 – 2024-12-31 | evidence 0001437749-26-012259 |
| FY 2023 | $-5.8M | 2023-01-01 – 2023-12-31 | evidence 0001437749-26-012259 |
| FY 2022 | $-2.5M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-024080 |
| FY 2021 | $-78.3k | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-016147 |
| FY 2020 | $-1.0M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-018473 |
| FY 2019 | $-1.3M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-007650 |
| FY 2018 | $-2.3M | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-004653 |
| FY 2017 | $-168.1k | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-003621 |
| FY 2016 | $508.4k | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-003009 |
| FY 2015 | $1.2M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-011870 |
| FY 2014 | $-167.2k | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002097 |
| FY 2013 | $117.4k | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-017813 |
| FY 2012 | $89.5k | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-018264 |
| FY 2011 | $-409.5k | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-017287 |
| FY 2010 | $-384.7k | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-017287 |
| FY 2009 | $-216.5k | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-017287 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ImmuCell Corporation — all facts · Revenue · Operating Income